Emerging evidence on PSA in the diagnosis of prostate cancer

This course discusses the evidence on PSA as the best available biomarker of the risk for current prostate cancer. This includes the prognostic value of PSA as a marker for future risk of PCa and as a marker for progression of BPH. The role of PSA for risk stratification of already documented PCa or for monitoring treatment responses is NOT covered. In addition, the factors influencing PSA are discussed.

This course is accredited with 1 CME credit until January 2015.

Small renal stone burden: Stone at inferior calyx

This course provides an overview of the epidemiology, predictors, research and management of lower pole stones.

This course was accredited with 1 CME credit until January 2013.

Ureteral stones management

This course provides an overview of ureteral stone management; the primary procedures for a stone free proximal, mid and distal ureter are discussed.

This course was accredited with 1 CME credit until January 2013.

NOTES and LESS Transvaginal nephrectomy

This course offers an introduction of Natural orifice transluminal endoscopic surgery (NOTES) and Laparo-Endoscopic Single-Site LESS) surgery. These types of surgery are discussed based on publications in various scientific journals.

This course was accredited with 1 CME credit until January 2013.